Т -клетка естественного убийцы
естественного убийцы T ( NKT ) Клетки представляют собой гетерогенную группу Т -клеток , которые имеют свойства как Т -клеток, так и природных клеток -киллеров . Многие из этих клеток распознают неполиморфную CD1D молекулу , молекулу антигена , которая связывает себя и иностранные липиды и гликолипиды . Они составляют только приблизительно 1% всех периферической крови Т -клеток . [ 1 ] Природные T -клетки не следует не путать с естественными клетками -киллерами и не убийственными Т -клетками (цитотоксические Т -клетки).
Номенклатура
[ редактировать ]Термин «NK T-клетки» впервые использовали у мышей для определения подмножества Т-клеток, которые экспрессировали маркер NK1.1 (CD161), связанный с природным киллером (NK). В настоящее время общепризнанно, что термин «клетки NKT» относится к CD1D-ограниченным Т-клеткам , присутствующим у мышей и людей, некоторые из которых коэкспрессируют сильно смещенные, полуинвариантные Т-клеточные рецептор и маркеры NK. [ 2 ]
Молекулярная характеристика
[ редактировать ]NKT cells are a subset of T cells that coexpress an αβ T-cell receptor, but also express a variety of molecular markers that are typically associated with NK cells, such as NK1.1. The best-known NKT cells differ from conventional αβ T cells in that their T-cell receptors are far more limited in diversity ('invariant' or 'type 1' NKT).[3] Они и другие CD1D-ограниченные Т-клетки ('NKT типа 2' распознают липиды и гликолипиды, представленные молекулами CD1D, членом семейства CD1 антиген-презентативных молекул, а не пептид - основных комплексов гистосовместимости (MHCS). Таким образом, клетки NKT важны для распознавания гликолипидов из организмов, таких как Mycobacterium , что вызывает туберкулез .
NKT cells include both NK1.1+ and NK1.1−, as well as CD4+, CD4−, CD8+ and CD8− cells. Natural killer T cells can share other features with NK cells, as well, such as CD16 and CD56 expression and granzyme production.[4][5]
Invariant natural killer T (iNKT) cells express high levels of and are dependent on the transcriptional regulator promyelocytic leukemia zinc finger for their development.[6][7]
Classification
[edit]Classification of natural killer T cells into three groups has been proposed:[2]
| Type 1 NKT | Type 2 NKT | NKT-like | |
|---|---|---|---|
| Other names | classical NKT invariant NKT (iNKT) Vα14i NKT (mouse) Vα24i NKT (human) |
non-classical NKT diverse NKT |
NK1.1+ T cells CD3+ CD56+ T cells |
| Restriction | CD1d | CD1d | MHC, other? |
| α-GalCer reactivity |
+ | - | - |
| T-cell-receptor repertoire | Vα14-Jα18: Vβ8.2, 7, 2 (mouse) Vα24-Jα18: Vβ11 (human) |
diverse | diverse |
Invariant NKT (iNKT) cells
[edit]The best-known subset of CD1d-dependent NKT cells expresses an invariant T-cell receptor (TCR) α chain. These are referred to as type I or invariant NKT cells (iNKT) cells. They are notable for their ability to respond rapidly to danger signals and pro-inflammatory cytokines. Once activated, they engage in effector functions, like NK transactivation, T cell activation and differentiation, B cell activation, dendritic cell activation and cross-presentation activity, and macrophage activation.
iNKT cells recognize lipid antigens presented by CD1d, a non-polymorphic major histocompatibility complex class I-like antigen presenting molecule. These cells are conserved between humans and mice. The highly conserved TCR is made of Va24-Ja18 paired with Vb11 in humans, which is specific for glycolipid antigens.[8] The best known antigen of iNKT cells is alpha-galactosylceramide (αGalCer), which is a synthetic form of a chemical purified from the deep sea sponge Agelas mauritianus.[9] iNKT cells develop in the thymus, and distribute to the periphery. They are most commonly found in the liver, but are also found in the thymus, spleen, peripheral blood, bone marrow and fat tissue. In comparison to mice, humans have fewer iNKT cells and have a wide variation in the amount of circulating iNKT cells.[8]
Currently, there are five major distinct iNKT cell subsets. These subset cells produce a different set of cytokines once activated. The subtypes iNKT1, iNKT2 and iNKT17 mirror Th Cell subsets in cytokine production. In addition there are subtypes specialized in T follicular helper-like function and IL-10 dependent regulatory functions.[10] Once activated iNKT cells can impact the type and strength of an immune response. They engage in cross talk with other immune cells, like dendritic cells, neutrophils and lymphocytes.[11] Activation occurs by engagement with their invariant TCR. iNKT cells can also be indirectly activated through cytokine signaling.[8]
While iNKT cells are not very numerous, their unique properties makes them an important regulatory cell that can influence how the immune system develops.[12] They are known to play a role in chronic inflammatory diseases like autoimmune disease, asthma and metabolic syndrome. In human autoimmune diseases, their numbers are decreased in peripheral blood. It is not clear whether this is a cause or effect of the disease. Absence of microbe exposure in early development led to increased iNKT cells and immune morbidity in a mouse model.[13]
Function
[edit]Upon activation, NKT cells are able to produce large quantities of interferon gamma, IL-4, and granulocyte-macrophage colony-stimulating factor, as well as multiple other cytokines and chemokines (such as IL-2, IL-13, IL-17, IL-21, and TNF-alpha).
NKT cells recognize protected microbial lipid agents which are presented by CD1d-expressing antigen presenting cells. This serves as a pathway for NKT cells to fight against infections and enhance the humoral immunity. The NKT cells provide support and help to B cells which act as a microbial defense and aid in targeting for B-cell vaccines.[14]
Significance
[edit]NKT cells seem to be essential for several aspects of immunity because their dysfunction or deficiency has been shown to lead to the development of autoimmune diseases such as diabetes, autoinflammatory diseases such as atherosclerosis, and cancers. NKT cells have recently been implicated in the disease progression of human asthma.[15]
The clinical potential of NKT cells lies in the rapid release of cytokines (such as IL-2, IFN-gamma, TNF-alpha, and IL-4) that promote or suppress different immune responses.
Most clinical trials with NKT cells have been performed with cytokine-induced killer cells (CIK).[16]
See also
[edit]- Cytotoxic T cell (killer T cell)
- List of distinct cell types in the adult human body
References
[edit]- ^ Jerud, ES; Bricard G; Porcelli SA (2006). "Natural Killer T cells: Roles in Tumor Immunosurveillance and Tolerance". Transfus. Med. Hemother. 33 (1): 18–36. doi:10.1159/000090193.
- ^ Jump up to: a b Godfrey, DI; MacDonald HR; Kronenberg M; Smyth MJ; Van Kaer L (2004). "NKT cells: what's in a name?". Nat. Rev. Immunol. 4 (3): 231–7. doi:10.1038/nri1309. PMID 15039760. S2CID 19442375.
- ^ de Araújo, ND; Gama, FM; de Souza Barros, M; Ribeiro, TLP; Alves, FS; Xabregas, LA; Tarragô, AM; Malheiro, A; Costa, AG (2021). "Translating Unconventional T Cells and Their Roles in Leukemia Antitumor Immunity". Journal of Immunology Research. 2021: 6633824. doi:10.1155/2021/6633824. PMC 7808823. PMID 33506055.
- ^ Van der Vliet, HJ; Nishi N; Koezuka Y; Peyrat MA; Von Blomberg BM; Van den Eertwegh AJ; Pinedo HM; Giaccone G; Scheper RJ (1999). "Effects of alphagalactosylceramide (KRN7000), interleukin-12 and interleukin-7 on phenotype and cytokine profile of human Va24+ Vb11+ T cells". Immunology. 98 (4): 557–563. doi:10.1046/j.1365-2567.1999.00920.x. PMC 2326955. PMID 10594688.
- ^ Vivier, E; Anfossi N (2004). "Inhibitory NK-cell receptors on T cells. Witness of the past, actors of the future". Nat Rev Immunol. 4 (3): 190–198. doi:10.1038/nri1306. PMID 15039756. S2CID 22320064.
- ^ Kovalovsky D, Uche OU, et al. (Sep 2008). "The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions". Nature Immunology. 9 (9): 1055–64. doi:10.1038/ni.1641. PMC 2662733. PMID 18660811.
- ^ Savage AK, Constantinides MG, et al. (Sep 2008). "The transcription factor PLZF directs the effector program of the NKT cell lineage". Immunity. 29 (3): 391–403. doi:10.1016/j.immuni.2008.07.011. PMC 2613001. PMID 18703361.
- ^ Jump up to: a b c Brennan, Patrick J.; Brigl, Manfred; Brenner, Michael B. (2013-02-01). "Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions". Nature Reviews Immunology. 13 (2): 101–117. doi:10.1038/nri3369. ISSN 1474-1733. PMID 23334244. S2CID 205491870.
- ^ Kawano, T.; Cui, J.; Koezuka, Y.; Toura, I.; Kaneko, Y.; Motoki, K.; Ueno, H.; Nakagawa, R.; Sato, H. (1997-11-28). "CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides". Science. 278 (5343): 1626–1629. Bibcode:1997Sci...278.1626K. doi:10.1126/science.278.5343.1626. ISSN 0036-8075. PMID 9374463.
- ^ Gapin, Laurent (2016-01-20). "Development of invariant natural killer T cells". Current Opinion in Immunology. 39: 68–74. doi:10.1016/j.coi.2016.01.001. ISSN 1879-0372. PMC 4801673. PMID 26802287.
- ^ Berzins, Stuart P.; Smyth, Mark J.; Baxter, Alan G. (2011-02-01). "Presumed guilty: natural killer T cell defects and human disease". Nature Reviews Immunology. 11 (2): 131–142. doi:10.1038/nri2904. ISSN 1474-1733. PMID 21267014. S2CID 22580270.
- ^ Ван Каер, Люк; Parekh, Vrajesh v.; Wu, Lan (2013-02-01). «Инвариантные естественные убийственные Т -клетки как датчики и менеджеры воспаления» . Тенденции в иммунологии . 34 (2): 50–58. doi : 10.1016/j.it.2012.08.009 . PMC 3615427 . PMID 23017731 .
- ^ Олшак, Торстен; Ан, дингвинг; Zeissig, Себастьян; Вера, Мигель Пинилла; Рихтер, Джулия; Франке, Андре; Гликман, Джонатан Н.; Зиберт, Рейнер; Барон, Ребекка М. (2012-04-27). «Микробное воздействие в раннем возрасте оказывает постоянное влияние на естественную функцию T -клеток на естественных убийцах» . Наука . 336 (6080): 489–493. Bibcode : 2012sci ... 336..489o . doi : 10.1126/science.1219328 . ISSN 0036-8075 . PMC 3437652 . PMID 22442383 .
- ^ Бай, Ли; Дэн, Шенглу; Ребуле, Рэйчел; Мэтью, Ребекка; Teytone, Luc; Сэвидж, Пол Б.; Бенделяк, Альберт (2013). «Природные взаимодействия-убийцы T (NKT) -B-клеток способствуют длительным реакциям антител и долговременной памяти на пневмококковые капсулярные полисахариды» . Труды Национальной академии наук Соединенных Штатов Америки . 110 (40): 16097–16102. BIBCODE : 2013PNAS..11016097B . doi : 10.1073/pnas.1303218110 . JSTOR 23749719 . PMC 3791701 . PMID 24043771 .
- ^ Кроми, Уильям Дж. Исследователи раскрывают причины архивирования астмы 2006-04-05 в газете Гарвардского университета в Гарвардском университете , 16 марта 2006 года.
- ^ Schmeel LC, Schmiel FC, Coch C, Schmidt-Wolf IG (2014). «Индуцированная цитокином-киллерами (CIK) в иммунотерапии рака: доклад Международного реестра по клеткам CIK (IRCC)». J Cancer Res Clin Oncol . 141 (5): 839–49. doi : 10.1007/s00432-014-1864-3 . PMID 25381063 . S2CID 11940173 .
{{cite journal}}: Cs1 maint: несколько имен: список авторов ( ссылка )